This story was updated following CVS Health's earnings call Wednesday morning. | The company reported improvements in its ...
Pricing issues have taken precedence as CVS Health’s (NYSE:CVS) pharmacy benefit manager, CVS Caremark, continues to hold off ...
CVS Health Inc. (NYSE:CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ:GILD) new HIV prevention drug Yeztugo to its commercial plans. In June, the U.S. Food and Drug Administration (FDA) ...
Zacks Investment Research on MSN
Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?
The Pharmacy & Consumer Wellness segment at CVS Health CVS is showing strong momentum, driven by the company’s focus on operational excellence and technological upgrades that improve the customer ...
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...
Louisiana has shifted one of its two large pharmacy benefits contracts for state employees away from CVS Health, but Gov. Jeff Landry and state lawmakers kept the most lucrative agreement with that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback